Myelin presentation to T cells in the central nervous system (CNS) sustains inflammation in multiple sclerosis (MS). CD4 + and CD8 + T cells contribute to MS, but only cells that present myelin to CD4 + T cells have been identified. We show that MHC class I-restricted myelin basic protein (MBP) was presented by oligodendrocytes and cross-presented by Tip-dendritic cells (DCs) during experimental autoimmune encephalomyelitis (EAE), an animal model of MS initiated by CD4 + T cells. Tip-DCs activated naive and effector CD8 + T cells ex vivo, and naive MBP-specific CD8 + T cells were activated in the CNS during CD4 + T cellinduced EAE. These results demonstrate that CD4 + T cell-mediated CNS autoimmunity leads to determinant spreading to myelin-specific CD8 + T cells that can directly recognize oligodendrocytes. npg
A r t i c l e s MS is a CNS autoimmune disease characterized by inflammatory, demyelinating lesions and axonal loss. MS is believed to be triggered by exposure to environmental factors that activate peripheral myelin-specific T cells, allowing them to cross the blood-brain barrier that normally restricts entry of naive T cells. The pathogenesis of MS has been studied in EAE, an animal model of MS that is induced by immunization with myelin antigens 1 . Infiltrating CD4 + T cells are reactivated in the CNS by local antigen-presenting cells (APCs) presenting MHC class II-restricted myelin epitopes 2, 3 . CD11c + DCs are critical for this reactivation step 4 . The ensuing inflammatory response recruits both monocytes that differentiate into MHC class II + APCs after entering the CNS 5, 6 and naive T cells that recognize myelin epitopes distinct from those recognized by the initial T cell population. Activation of these naive T cells leads to a phenomenon known as determinant spreading 7, 8 , which is important for sustaining chronic inflammation.
The mechanisms studied in EAE center on the activity of myelinspecific CD4 + T cells. However, CD8 + T cells are strongly implicated in the pathogenesis of MS 9, 10 . CD8 + T cells outnumber CD4 + T cells in both acute and chronic MS lesions 11, 12 . The number of CD8 + T cells and macrophages also correlates with the extent of axonal damage 13, 14 . CD8 + T cells appear more antigen-experienced than CD4 + T cells in the CNS and blood of individuals with MS, and CD8 + but not CD4 + T cell clones persist over time in both of these compartments 11, [15] [16] [17] . Neuroantigen-specific CD8 + , but not CD4 + , T cells are also more abundant in the CNS of individuals with MS compared to healthy controls 18, 19 . The contribution of CD8 + T cells to CNS autoimmunity is not well understood. Some studies attribute an immunoregulatory function to CD8 + T cells in CD4 + T cell-induced EAE 10 , although the antigen specificity of the CD8 + T cells in these studies has not been defined.
Other studies have shown that myelin-specific CD8 + T cells not only potentiate CD4 + T cell-mediated EAE 20 but also mediate CNS autoimmune disease on their own [21] [22] [23] . These diverse results suggest that CD8 + T cells may have a complex role in CNS autoimmunity that can result in exacerbation or amelioration of disease.
Myelin-specific CD8 + T cells must recognize their cognate antigen in the CNS to influence inflammatory responses; however, APCs presenting MHC class I-restricted myelin epitopes have not been identified. We generated unique reagents to detect a MHC class Irestricted epitope of MBP on the surface of APCs. We analyzed CNS cells from mice with EAE induced by CD4 + T cells rather than CD8 + T cells to eliminate the possibility that activated CD8 + T cells may lyse APCs presenting their cognate antigen and prevent their detection. We found that MBP was cross-presented by Tip-DCs derived from inflammatory monocytes that accumulated in the CNS during CD4 + T cell-mediated EAE. These DCs were the only CNS cells capable of activating naive CD8 + T cells directly ex vivo. Consistent with this, we found that naive CD8 + MBP-specific T cells were recruited to the CNS during EAE and activated in situ, demonstrating that determinant spreading to CD8 + T cells can occur during CD4 + T cell-induced EAE. MHC class I-restricted MBP was also directly presented by oligodendrocytes that were induced to express MHC class I during EAE, indicating that these cells as well as the Tip-DCs are potential targets of myelin-specific CD8 + T cells in the CNS.
RESULTS

CD11c + DCs presented MHC class I-restricted MBP
To identify CNS cells that present MHC class I-restricted MBP, we used C3HeB/Fej mice expressing a transgenic myelin-specific T cell antigen receptor (TCR) composed of V α 8 and V β 6 (designated A r t i c l e s '8.6' mice). The transgenic TCR expressed by T cells in these mice is specific for MBP79-87 presented by H-2K k (referred to as MBP-H-2K k ) 24 . CD8 + TCR-transgenic 8.6 T cells become tolerized in wildtype mice; however, they can be isolated from MBP-deficient mice and used to detect cells presenting endogenous MBP epitopes directly ex vivo 24 . To maximize the sensitivity of detection of MBP-H-2K k epitope in this assay, we generated effector CD8 + 8.6 T cells that secrete interferon-γ (IFN-γ) rapidly upon exposure to APCs presenting MBP-H-2K k . We first assessed whether bulk CNS cells from mice with CD4 + T cell-mediated EAE or from healthy mice could stimulate CD8 + 8.6 T cell responses directly ex vivo. We isolated CNS cells from C3HeB/Fej mice at the peak of EAE induced by immunization with recombinant myelin oligodendrocyte glycoprotein (rMOG), which activates encephalitogenic CD4 + T cells in this strain 25 . Exposure of 8.6 T cells to bulk mononuclear CNS cells isolated from mice with EAE triggered production of IFN-γ ( Fig. 1a) . Exposure to CNS cells from healthy mice triggered a smaller but detectable percentage of 8.6 effector T cells to produce IFN-γ, indicating that MBP-H 2K k is presented constitutively at low abundance in the CNS.
We also generated an antibody to the MBP-H-2K k complex by immunizing C3HeB/Fej mice with recombinant H-2K k protein that we refolded with β2 microglobulin and MBP79-87 peptide. Using a cellbased enzyme-linked immunosorbent assay (ELISA), we identified antibodies that bind specifically to RMA-S-H-2K k cells pulsed with MBP79-87 peptide 26 . We generated over 20 MBP-H-2K k -specific hybridomas; the antibody designated 12H4 was used in the majority of our studies. We confirmed the specificity of the 12H4 antibody by showing that 12H4 antibody binds to RMA-S-H-2K k cells pulsed with MBP79-87 but not to RMA-S-H-2K k cells pulsed with simian virus 40 (SV40) large T antigen peptide that also associates with H-2K k (Fig. 1b) . The 12H4 antibody also specifically inhibits production of IFN-γ by 8.6 effector T cells in response to either MBP79-87-pulsed splenocytes or CNS cells presenting endogenous MBP but did not inhibit the response of T antigen-specific T cells to splenocytes pulsed with T antigen peptide ( Fig. 1c) .
We used the 12H4 antibody to identify which CNS cell types express MBP-H-2K k , and sorted these populations and incubated them with 8.6 effector T cells to determine whether these cell types could trigger functional T cell responses. We stained CNS cells from mice with EAE with the 12H4 antibody and with antibodies to cell-surface markers that identify DCs, macrophages and microglia. Gating strategies used for analyses and sorting of the CNS cell types are shown in Supplementary Figure 1 . CD11c + cells accounted for the highest percentage of 12H4 + cells and stimulated the most production of IFN-γ by 8.6 effector T cells ( Fig. 2a,b) . The percentage of 12H4 + macrophages was less compared to 12H4 + CD11c + DCs ( Fig. 2a and Supplementary Fig. 2a ), which may account for the reduced production of IFN-γ by 8.6 T cells incubated with macrophages ( Fig. 2b) . Only a small percentage of microglia were 12H4 + (Fig. 2a) , and production of IFN-γ elicited by microglia was only slightly above background ( Fig. 2b) . Although there were fewer DCs than macrophages in the CNS infiltrate, the absolute number of 12H4 + DCs was greater than the number of 12H4 + macrophages (Supplementary Fig. 2b) . Thus, CD11c + 
Cross-presenting DCs are derived from inflammatory monocytes
The majority of CD11c + cells in the CNS of rMOG-immunized C3HeB/Fej mice expressed CD11b ( Supplementary Fig. 3) , consistent with the predominance of myeloid DCs (mDCs) in the CNS reported for other CD4 + T cell-mediated EAE models 4, [27] [28] [29] . The 12H4 + DCs were also CD11b + ; the few CD11c + CD8 + and CD11c + B220 + DCs detected in the CNS did not present MBP-H-2K k (Supplementary Fig. 3 ). Previous studies demonstrated that both mDCs and macrophages that accumulate in the CNS during CD4 + T cell-mediated EAE arise primarily from CD11b + Ly6C + CD62L + F4/80 + inflammatory monocytes that infiltrate the CNS via a CCR2-dependent mechanism 5,6,30 . The 12H4 + DCs also exhibited a CD11c + CD11b + Ly6C + F4/80 + MHC class II + CX3CR1 − phenotype, consistent with cells differentiated from inflammatory monocytes ( Fig. 3) , although the 12H4 + DCs were CD62L − . CCR2 expression on 12H4 + DCs also differed from monocytes in that it ranged from intermediate to negative. Downregulation of CCR2 by monocytes entering an environment with elevated expression of interleukin 1 (IL-1) and tumor necrosis factor (TNF) has been previously described 31 , and this may be the case for CD62L as well.
Because not all of the mDCs in the CNS were 12H4 + , we investigated whether this subset exhibited any similarities to other DC subsets known to be proficient in cross-presentation. The spleen contains a DC subset that is proficient in cross-presentation and exhibits a unique CD8αα + CD11b − CD205 + phenotype 32 with variable expression of CD103 (ref. 33 ). This DC subset is generated via a distinct differentiation program dependent on the transcription factors BATF3 and IRF8 as well as the inhibitor of DNA protein Id2 (ref. 34) . Nonlymphoid tissues also contain BATF3-IRF8-Id2 lineage DCs that are proficient in cross-presentation and are phenotypically similar (CD11b − CD103 + CD205 + ) to splenic CD8 + DCs except that they do not express CD8 (ref. 34 ). The MBP-H-2K k+ APCs in the CNS of mice with EAE differed from these DC subsets in that they were CD11b + ( Fig. 3 ) and CD205 − (data not shown). We analyzed expression of CD103 on 12H4 + cells to determine whether cells proficient in cross-presentation also expressed this integrin. We observed a broad range of CD103 expression on CD11c + cells in the CNS; cells that expressed an intermediate amount of CD11b expressed the most CD103 ( Fig. 4a) . However, these CD103 hi CD11b int cells did not present MBP-H-2K k . Instead, MBP-H-2K k was expressed only on cells expressing intermediate amounts of CD103 ( Fig. 4a) , which corresponded to cells expressing the most CD11b. Together, the expression patterns of CD11b and CD103 define a unique CD11b hi CD103 int phenotype for MBP-H-2K k+ cells that differs from that seen on other DCs specialized in cross-presentation.
To confirm that MBP-H-2K k DCs are distinct from peripheral DCs specialized in cross-presentation, we compared the expression of Batf3, Irf8 and Id2 in 12H4 + CD103 int and 12H4 − CD103 − DCs sorted from the CNS of mice with EAE and in CD8 + and CD8 − DCs sorted from the spleen. We also analyzed expression of Tlr3 and the chemokine receptor Figure 3 MBP-H-2K k+ DCs in mice with EAE are phenotypically similar to tissue-infiltrating inflammatory monocytes. Flow cytometric analyses of CNS cells from mice with EAE stained with the 12H4 antibody and antibodies to CD11c, CD45 and the cell-surface antigens indicated for each plot. Analyses were gated on CD45 hi CD11c + cells. Peripheral blood monocytes were also isolated from rMOG-immunized mice and stained for CD11b, Ly6C and CCR2; CCR2 expression is shown on CD11b + Ly6C + gated cells in the lower right plot. Numbers in quadrants indicate percent cells in each. Data are representative of 2 to 3 independent experiments for each cell marker. A r t i c l e s Xcr1 that is expressed on CD8αα + DCs in the mouse and on the human homolog of this DC subset. Cell-surface proteins encoded by these genes are frequently observed on cross-presenting DCs in the periphery. As expected, splenic CD8 + DCs expressed significantly more Irf8, Id2, Tlr3, Batf3 and Xcr1 transcripts compared to CD8 − DCs, (Fig. 4b) .
In contrast, we observed no significant differences in expression of any of these transcripts between 12H4 − CD103 − and 12H4 + CD103 int CNS DCs (Fig. 4b) .
Taken together, the phenotype and gene expression pattern are not consistent with MBP-H-2K k+ DCs arising from the same BATF3-IRF8-Id2 lineage as peripheral DCs that are specialized in cross-presentation, supporting the notion that MBP-H-2K k DCs originate from inflammatory monocytes. We then analyzed the expression in MBP-H-2K k APCs of Zbtb46, which encodes a transcription factor whose expression distinguishes classical DCs from other immune cells 35, 36 . Both CD8 + and CD8 − splenic DCs expressed Zbtb46, and we detected low expression of Zbtb46 in 12H4 − CD103 − DCs as well. In contrast, we did not detect Zbtb46 transcripts in 12H4 + CD103 int DCs (Fig. 4b) , indicating that these DCs are not derived from the classical DC lineage.
MBP is cross-presented by Tip-DCs
We investigated whether MBP-H-2K k+ DCs were Tip-DCs characterized by TNF and inducible nitric oxide synthase (iNOS) expression 37 that are derived from activated monocytes rather than the classical DC lineage 35, 36 . Approximately 50% of MBP-H-2K k+ DCs isolated from mice with EAE expressed TNF directly ex vivo, and iNOS transcripts were also preferentially expressed in 12H4 + CD103 int DCs compared to 12H4 − CD103 − DCs (Fig. 5a) . We detected only low amounts of transcripts encoding IL-12 in 12H4 + and 12H4 − CNS DCs in mice with EAE (data not shown). MBP-H-2K k+ DCs lacked transcripts encoding CCR7 (Fig. 5a) , whereas 12H4 − CD103 − DCs expressed high levels of transcripts encoding this chemokine receptor. Together, these data indicate that MBP-H-2K k+ APCs are Tip-DCs derived from inflammatory monocytes that infiltrate the inflamed CNS and do not traffic to draining lymph nodes.
To confirm that the Tip-DCs are cross-presenting MBP rather than synthesizing MBP and directly presenting it, we analyzed 12H4 + CD103 int and 12H4 − CD103 − cells isolated from mice with EAE for expression of transcripts encoding classic MBP and golli-MBP. Golli-MBPs are a family of proteins that are not incorporated into myelin but that are encoded in part by exons that also encode classic MBPs, including the exon that encodes MBP79-87. Golli-MBPs are expressed in the nervous system and by multiple types of immune cells, including DCs 38 . Oligonucleotide primers specific to a classic Mbp transcript amplified a strong signal from CNS tissue but did not amplify transcripts from either 12H4 + CD103 int DCs or 12H4 − CD103 − DCs (data not shown). As expected, we detected golli-Mbp transcripts in both populations of DCs. However, golli-Mbp was transcribed to a greater extent in 12H4 − CD103 − DCs compared to 12H4 + CD103 int DCs, even though 12H4 − CD103 − DCs do not express MBP-H-2K k on the surface (Fig. 5b) . Similarly, we did not detect 12H4 + thymocytes or 12H4 + T cells in peripheral lymphoid tissues, even though these cells synthesize golli-MBP (data not shown). This result indicates that the expression of MBP-H-2K k on the surface of DCs occurs via cross-presentation of exogenous myelin.
Previous studies of determinant spreading showed that naive, myelin-specific CD4 + T cells recruited to the CNS during EAE are activated in situ rather than in peripheral lymph nodes 28 . To determine whether MBP-H-2K k+ DCs could promote determinant spreading to naive CD8 + T cells, we investigated whether they could activate naive CD8 + T cells. We sorted CD11c + DCs, macrophages and microglia from the CNS of mice with EAE and cultured these cells with naive 8.6 T cells. The 8.6 T cells proliferated only in response to DCs presenting endogenous MBP (Fig. 5c) . To determine whether naive CD8 + T cells infiltrate the CNS during EAE and become activated by MBP-H-2K k+ APCs, we used a different TCR-transgenic line in which the T cells express a transgenic TCR comprised of V α 8 and V β 8 (designated 8.8 mice) that is also specific for the same MBP-H-2K k epitope 24 . In contrast to 8.6 mice, 8.8 T cells do not undergo T cell tolerance, allowing A r t i c l e s the periphery to be populated with non-activated MBP-specific CD8 + T cells. We induced EAE by adoptive transfer of genetically marked CD4 + rMOG-specific T cells into 8.8 mice, and analyzed cells isolated from the CNS and spleen at the peak of disease by flow cytometry. Host 8.8 T cells comprised an average of 11% of the total T cell population in the CNS (data not shown, n = 9), demonstrating that CD8 + 8.8 T cells that had not been activated in the periphery enter the CNS during CD4 + T cell-induced EAE. Whereas the 8.8 T cells in the spleen exhibited a naive phenotype, the 8.8 T cells in the CNS exhibited an activated phenotype (CD44 hi CD62L lo CD69 hi ) in the CNS (Fig. 5d) . It is possible that the 8.8 CD8 + T cells were activated in the cervical lymph nodes rather than in the CNS; however, 12H4 + DCs were barely detectable in cervical lymph nodes, and the percentage of 12H4 + DCs in the CNS was typically much higher than that seen in lymph nodes (Supplementary Fig. 4 ). Together these results support the notion that MBP-H-2K k+ DCs generated in the CNS during CD4 + T cell-induced EAE can activate CD8 + T cells specific for a different myelin epitope that infiltrate the inflamed tissue.
Oligodendrocytes are induced to express MBP-H-2K k in EAE Under healthy conditions, nonhematopoietic CNS cells do not express MHC molecules. We investigated whether the inflammatory milieu generated during CD4 + T cell-mediated EAE induced MHC class I expression on these cells, allowing them to present MBP-H-2K k .
Oligodendrocytes are of particular interest as they synthesize MBP. Astrocytes also present antigen to CD8 + and CD4 + T cells under some circumstances 39 . Cerebral endothelial cells have also been reported to present peptide that was noninvasively injected into the CNS to CD8 + T cells 40 , suggesting that these cells might present MBP peptides derived from degraded myelin during EAE. We used the 12H4 antibody to detect presentation of MBP-H-2K k by these cells, and then sorted the individual cell types from the CNS of mice with EAE and cultured them with effector 8.6 T cells to analyze functional antigen presentation. We detected no MBP-H-2K k complexes on astrocytes or endothelial cells, and neither cell type stimulated production of IFN-γ by effector 8.6 T cells (Supplementary Fig. 5) . In contrast, MBP-H-2K k was detected on oligodendrocytes in mice with EAE (Fig. 6a) , and these cells triggered production of IFN-γ by 8.6 effector T cells (Fig. 6b) , indicating that oligodendrocytes could be direct targets of MBP-specific CD8 + T cells under inflammatory conditions. The observation that some oligodendrocytes express MBP-H-2K k shortly after the onset of clinical disease suggested the possibility that A r t i c l e s CD8 + T cell-mediated lysis of oligodendrocytes may be required to provide a source of MBP that is then presented by DCs. To investigate this possibility, we analyzed MBP-H-2K k expression on oligodendrocytes and CD45 + APCs during the preclinical stage of EAE. In mice induced for CD4 + T cell-mediated EAE, we detected MBP-H-2K k expression on CD45 + CNS cells collected from the mice before onset of clinical signs (Supplementary Fig. 6) . In contrast, we detected a low amount of MHC class I on oligodendrocytes, but the cells did not yet express MBP-H-2K k . These data indicate that MBP-H-2K k expression on oligodendrocytes is not required before expression on DCs and macrophages.
Distinct DCs present MBP-H-2K k in the healthy CNS The healthy CNS must contain MBP-H-2K k+ APCs because adoptive transfer of MBP-specific CD8 + T cells triggers autoimmunity in the absence of CD4 + T cells 41 . Staining with the 12H4 antibody detected MBP-H-2K k on DCs and macrophages in naive mice, whereas microglia expressed very little MHC class I and no detectable MBP-H-2K k (Fig. 7a) . Different cell types were sorted from the CNS of healthy mice and cultured with effector 8.6 T cells; DCs and macrophages were sorted together due to their low numbers in the healthy CNS.
Only the pooled DC and macrophage fraction triggered production of IFN-γ by effector CD8 + T cells (Fig. 7b) , indicating that resident DCs and/or macrophages in the healthy CNS constitutively present MBP-H-2K k . Consistent with a lack of inflammation, CNS DCs in healthy mice expressed less CD80 and CD86 compared to CNS DCs from sick mice (Fig. 7c) . The MBP-H-2K k+ CNS DCs in healthy mice were Ly6C − CD11b + F4/80 + CD103 − and expressed CX3CR1 and CCR2 (Fig. 7d) . Thus, MBP-H-2K k+ DCs in the healthy CNS exhibit a noninflammatory phenotype distinct from both cross-presenting DCs in peripheral tissues and from CNS DCs observed under the inflammatory conditions of EAE.
DISCUSSION
APCs that present myelin antigen in the CNS activate the T cells that propagate the inflammatory response and therefore could be therapeutic targets in MS. Although there is compelling evidence that both CD8 + and CD4 + T cells contribute to the pathogenesis of MS, only APCs that present myelin antigen to CD4 + T cells have been characterized. In animal models of MS, both pathogenic and immunoregulatory activities have been attributed to CD8 + T cells. Whereas the mechanisms underlying either of these potential activities are not known, they may reflect interactions with different types of APCs.
We used CD8 + TCR transgenic T cells specific for a MHC class Irestricted epitope of MBP and a newly generated antibody specific for the same epitope to identify cells that present MHC class I-restricted MBP to CD8 + T cells. Although it is not known whether CD4 + or CD8 + T cells initiate MS, we used a CD4 + T cell-mediated EAE model for these studies for two reasons. First, mice expressing myelinspecific CD4 + transgenic TCRs develop spontaneous EAE with many similarities to MS, supporting the idea that models in which CD4 + T cells initiate disease are physiologically relevant to MS 1 . Second, the disease would initially involve predominantly activated CD4 + T cells, minimizing the possibility that activated myelin-specific CD8 + T cells infiltrating the CNS would lyse APCs presenting their cognate antigen and prevent their detection. We showed in CD4 + T cell-mediated EAE that MHC class I-restricted MBP was predominantly presented by DCs whose phenotype and function indicate that they are Tip-DCs, and that these DCs activated naive MBP-specific CD8 + T cells. Macrophages were much less efficient in presenting MBP-H-2K k , and microglia, astrocytes and endothelial cells did not present MBP to CD8 + T cells. Oligodendrocytes were induced to express MHC class I and present MBP-H-2K k under the inflammatory conditions generated during CD4 + T cell-mediated EAE.
Presentation of MBP-H-2K k largely by DCs is consistent with the critical role of DCs in promoting inflammation during CNS autoimmune disease. In individuals with MS, DCs accumulate in the meninges and parenchymal lesions 4, 42, 43 , and mature DCs are observed lining the blood vessels in noninflamed CNS tissue where they are well-positioned to reactivate infiltrating T cells 4 . In CD4 + T cell-mediated EAE, DCs are required to initiate disease 4 , and CD11b + mDCs were the only cells that could activate naive CD4 + T cells, even though macrophages phagocytosed comparable amounts of myelin and could activate effector CD4 + T cells 28 . The proinflammatory DCs present early in CD4 + T cell-mediated EAE decreased in number later in the course of disease, whereas the number of DCs with a more immature phenotype that are less efficient in stimulating CD4 + T cells increased 29 . The mechanism responsible for the decline in pro-inflammatory DCs has not been described.
Our data demonstrate that the DCs generated in the CNS during CD4 + T cell-induced EAE that present MHC class I-restricted MBP are CD11b + Tip-DCs that are likely derived from infiltrating inflammatory monocytes. This conclusion is based on the phenotypic similarity to inflammatory monocytes, the predominant production of TNF and iNOS without IL-12, and the lack of expression of the Zbtb46 transcription factor that is selectively expressed by classical DCs and their progenitors 35, 36 . The MBP-H-2K k+ DCs are also distinguished by their intermediate expression of CD103, an integrin whose expression is correlated with, but not required for, cross-presentation by DCs 33 . Neither CD103 − nor CD103 hi DCs presented MBP-H-2K k , and virtually all CD103 int DCs were 12H4 + , indicating that the MBP-H-2K k+ DCs are a distinct DC subset that can be phenotypically defined by these markers. Our data demonstrate that presentation of MBP-H-2K k by Tip-DCs occurs via cross-presentation. We did not detect classic Mbp transcripts in MBP-H-2K k+ DCs, and the low amount of golli-Mbp transcription was not sufficient to allow direct presentation of MBP-H-2K k because 12H4 − DCs expressed as many or more transcripts encoding golli-MBP as 12H4 + DCs did.
There are several mechanisms by which the Tip-DCs could acquire and present MBP-H-2K k . Tip-DCs could phagocytose myelin debris or dead oligodendrocytes and transfer the antigen to the cytosol where it is processed and loaded onto MHC class I molecules for crosspresentation. Under steady-state conditions, oligodendrocytes can produce exosomes containing myelin epitopes that are preferentially taken up by microglia 44 . If these exosomes are taken up under inflammatory conditions by macrophages and DCs, they could be a potential source of MBP peptides for these APCs during EAE, similar to bone marrow-derived DCs that obtain antigen from exosomes and load it onto their own MHC class I molecules 45 . Another possibility is that the Tip-DCs acquire preformed MBP peptide-MHC class I complexes from the membranes of neighboring cells, such as oligodendrocytes, via trogocytosis 46, 47 . This cell contact-dependent process can result in 'cross-dressed' DCs that can activate both naive and memory CD8 + T cells in vitro 45 . However, cross-dressed DCs cannot activate naive CD8 + T cells in vivo, at least in the context of a viral infection. As our data show that naive CD8 + cells enter the CNS and are activated in situ, cross-dressing seems an unlikely mechanism for presentation of MBP-H-2K k by Tip-DCs.
Our findings indicate that determinant spreading can occur in the CNS between CD4 + and CD8 + myelin-specific T cells. The Tip-DCs are likely the only cell type in the CNS that can activate naive CD8 + T cells, npg A r t i c l e s as these are the only cells that activated naive 8.8 T cells directly ex vivo. CD8 + T cell activation in the CNS is consistent with the lack of CCR7 on MBP-H-2K k+ DCs, as this chemokine receptor facilitates trafficking of classical DCs from peripheral tissues to lymph nodes. CCR7 is expressed on MBP-H-2K k− DCs in the inflamed CNS, and DCs that cross-present tumor antigens acquired in the CNS under less inflammatory conditions migrate to peripheral lymph nodes 48 . Thus, lack of CCR7 may be a characteristic of Tip-DCs in inflamed tissues.
DCs were also the predominant APCs that presented MBP-H-2K k in the healthy CNS. The MBP-H-2K k+ CNS DCs in healthy mice did not exhibit the inflammatory phenotype of the DCs in mice with EAE, but their CD11b + CD103 − F4/80 + phenotype also did not resemble other tissue-resident DCs specialized in cross-presentation. The coexpression of CCR2 and CX3CR1 on these DCs is unusual, although it is not known whether either chemokine receptor is required for their localization in the healthy CNS. APCs that reactivate infiltrating myelin-specific T cells are found in the subarachnoid space 37, 49 ; and the role of particular chemokine receptors in facilitating entry of DCs into this compartment is not known. MBP-H-2K k+ APCs in the healthy CNS can stimulate previously activated CD8 + T cells in vitro, suggesting that they have the potential to reactivate CD8 + T cells that had been primed in the periphery.
Our data demonstrate that oligodendrocytes may be lytic targets of activated, MBP-specific CD8 + T cells during EAE, consistent with reports that human MBP-specific CD8 + T cells can lyse oligodendrocytes in a MHC-restricted fashion without addition of exogenous antigen 50 , and that CD8 + T cells containing polarized cytolytic granules are seen in close proximity to oligodendrocytes and demyelinated axons in the CNS of individuals with MS 14 . Because RNA transport mechanisms allow MBP synthesis to take place in myelin membranes distal from the oligodendrocyte cell body, MBP-H-2K k complexes could be expressed on the myelin sheath where they can engage CD8 + T cells. Endothelial cells and astrocytes did not present MBP-H-2K k , suggesting that astrocytes contribute to CD8 + T cell activation primarily via cytokine production 9 and that endothelial cells do not have a role in enhancing CD8 + T cell recruitment to the CNS via MBP peptide presentation 40 .
Our findings that MHC class I-restricted MBP is presented by both Tip-DCs and by oligodendrocytes suggest the intriguing hypothesis that CD8 + T cells could exert both pathogenic and immunoregulatory activities in the CNS during EAE. CD8 + T cells activated by Tip-DCs could exacerbate disease via production of IFN-γ, and the CD8 + T cells could also contribute to tissue damage by lysing oligodendrocytes. However, the Tip-DCs themselves could also become lytic targets of the newly activated CD8 + T cells. Loss of these DCs may reduce inflammation by decreasing the number of APCs available to stimulate both CD4 + and CD8 + T cells in the CNS. Ongoing axonal destruction in inactive MS lesions that appear to have few inflammatory cells (referred to as 'low-burning' axonal damage) has been described 51 and it is possible that myelin-specific CD8 + T cells may be important in this process. It would also be of interest to determine whether there is an increase in myelin-specific CD8 + T cell activity during the transition from relapsing-remitting to secondary progressive MS, as this phase of disease is characterized by a decrease in inflammation with ongoing axonal degeneration.
METHODS
Methods and any associated references are available in the online version of the paper.
